Publication | Closed Access

Adjusted Clopidogrel Loading Doses According to Vasodilator-Stimulated Phosphoprotein Phosphorylation Index Decrease Rate of Major Adverse Cardiovascular Events in Patients With Clopidogrel Resistance

ThrombosisHypertensionClopidogrel ResistanceCardiovascular DiseaseAntihypertensive TherapyPharmacologyVascular BiologyPharmacotherapyPlatelet AntagonistMedicineClopidogrel LoadingAtherosclerosisDyslipidemia